IAPP

Official Full Name

islet amyloid polypeptide

Organism

Homo sapiens

Gene ID

3375

Background

This gene encodes a member of the calcitonin family of peptide hormones. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. Human patients with type 1 and advanced type 2 diabetes exhibit reduced levels of the encoded hormone in blood and pancreas. This protein also exhibits a bactericidal, antimicrobial activity. [provided by RefSeq, Jul 2016]

Synonyms

DAP; IAP

Cat.No.	Product Name	Price
CSC-DC007374	Panoply™ Human IAPP Knockdown Stable Cell Line	Inquiry
CSC-SC007374	Panoply™ Human IAPP Over-expressing Stable Cell Line	Inquiry
CSC-SC007374-1	Human IAPP Stable Cell Line - HeLa	Inquiry

Cat.No.	Product Name	Price
AD07849Z	Human IAPP adenoviral particles	Inquiry
LV15120L	human IAPP (NM_000415) lentivirus particles	Inquiry

Cat.No.	Product Name	Price
SHH137369	shRNA set against Mouse Iapp(NM_010491.2)	Inquiry
SHW005891	shRNA set against Chicken IAPP (NM_205397)	Inquiry

Cat.No.	Product Name	Price
CDCR377452	Rat Iapp ORF Clone(NM_012586.2)	Inquiry
CDFR010405	Rat Iapp cDNA Clone(NM_012586.2)	Inquiry
MiUTR1M-05868	IAPP miRNA 3'UTR clone	Inquiry
MiUTR4H-TG04380	IAPP miRNA 3'UTR clone	Inquiry
CDCB167366	Chicken IAPP ORF Clone (NM_205397)	Inquiry
CDCH386424	Mouse IAPP ORF clone(NM_010491.2)	Inquiry
CDCL184639	Human IAPP ORF clone(NM_000415.2)	Inquiry

Detailed Information

Recent Research Progress

IAPP, also called amylin, is secreted from pancreatic beta cells. IAPP is most studied since it has been found plays important roles in diabetes and Alzheimer’s disease (AD), both of which cannot be cure yet. IAPP is a prevalent autoantigen in diabetes cause several of its epitopes can activate either CD4 or CD8 T cells in NOD mice and T1D subjects. In addition, recently evidences show that IAPP aggregates elicit interleukin-1B (IL1B) secretion from innate immune cells as strong proinflammatory stimuli. Moreover, the pro-inflammatory properties and toxic effects on beta cells of IAPP are implicated in the pathology of Type 2 diabetes (T2D). Besides, IAPP is the main constituent of insoluble amyloid deposits in T2D. Intriguingly, IAPP deposits also be found in the brain tissue of patients with AD, contributing to the pathophysiology of the disease. Researches show that human IAPP has high binding affinity to Aβ, an important factor in AD. What’s more, they also share many biophysical and physiological properties, and exert similar cytotoxic mechanisms when they aggregate.

Thus, IAPP seems a novel link between T2D and AD. Increasing evidences reveal that there are many possible pathways by which IAPP aggregates accelerate the progression of AD in diabetic patients, such as the interaction with Aβ, instigation generic toxic cellular responses, interaction with lipid components of cell membrane, triggering inflammatory responses, inducing a pattern of oxidative stress genes which lead to cell apoptosis, and working with the pro-apoptotic c-Jun N-terminal kinase (JNK) signaling pathway. People speculated that cerebral IAPP is derived from pancreatic islet b-cells during the progression of T2D, and then flows into the Central nervous system (CNS) via the circulation. Result that parts of IAPP deposits are detected in blood vessel walls and pericapillary spaces in the brain has further supported this hypothesis. Additionally, as shown as Figure 1, IAPP oligomers can cross the blood brain barrier (BBB) by inducing inflammatory cytokines to destroy the integrity of the BBB.

Figure 1. The potential mechanisms of amyloidogenic IAPP-induced AD development.
(Zhang Y, et al. 2018)

IAPP plays many physiological roles in diabetes and AD with its heterodimer receptor, distributing in the brain widely. Among those roles, one of the most significant role of IAPP is to be a physiologic regulator of food consumption. Besides its effects on appetite, studies also demonstrated that IAPP is to serve as an adiposity signal in the brain to control body weight. It has been showed that IAPP activates the sympathetic nerve, increasing brown adipose tissue (BAT) activity and regulating total energy expenditure. With the overexpression of RAMP1, a component of the IAPP receptor complex, this metabolic effect of IAPP is enhanced in the mice. However, the BAT response to IAPP abolished when pretreatment with the IAPP receptor antagonist AC187, indicating that the sympathetic effects of IAPP are receptor- mediated. Previous studies have demonstrated that IAPP contributes to glucose homeostasis by suppressing glucagon secretion in the postprandial state, which indicates the beneficial effects of IAPP on glucose homeostasis. On the other side, IAPP delays absorption of glucose from the small intestine into the circulation by signaling the stomach to slow gastric emptying.

Figure 2. Physiological role of amylin. (Michaela Press, et al, 2018)

References:

Denroche H C, et al. IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants. Journal of Molecular Endocrinology, 2018, 60(2): R57.
Zhang Y, et al. Islet Amyloid Polypeptide: Another Key Molecule in Alzheimer's Pathogenesis? Progress in Neurobiology, 2017, 153:100.
Press M, et al. Protein aggregates and proteostasis in aging: amylin and Î²-cell function. Mechanisms of Ageing & Development, 2018.
Sciacca M, et al. Amyloid growth and membrane damage: Current themes and emerging perspectives from theory and experiment son Aβ and hIAPP. Biochimica et Biophysica Acta (BBA) - Biomembranes, 2018.

Quick Inquiry